HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.

AuthorsJosé M Calvo-Villas, Adrián Alegre, Carmen Calle, Miguel T Hernández, Ricarda García-Sánchez, Gema Ramírez, GEM-PETHEMA/Spanish Myeloma Group, Spain
JournalEuropean journal of haematology (Eur J Haematol) Vol. 87 Issue 3 Pg. 281-4 (Sep 2011) ISSN: 1600-0609 [Electronic] England
PMID21557775 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Thalidomide
  • Lenalidomide
Topics
  • Humans
  • Lenalidomide
  • Multiple Myeloma (drug therapy)
  • Salvage Therapy
  • Survival Analysis
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: